HOME > TOP STORIES

TOP STORIES

ORGANIZATION Industry Wants Continued Dialogue to Keep Price Maintenance Premium in Place: Janssen Japan Chief

September 13, 2017
REGULATORY MOF Budget Examiner Questions Price Maintenance Premium, Says Its Impact Amounts to Over 253 Billion Yen in FY2017

September 12, 2017
REGULATORY MHLW to Draft GL on Use of Real World Data in Application Filings to Promote Development of Drugs for Rare Diseases

September 12, 2017
ORGANIZATION Daiichi Sankyo’s Hirano to Replace Kamoya as Chuikyo Pharma Rep

September 11, 2017
ORGANIZATION Plasma Fraction Products Should Remain in List of Essential Drugs: Blood Products Association Exec

September 11, 2017
BUSINESS Pres. Fredrickson Leaves AZ Japan Unit after 14 Months in Office

September 11, 2017
REGULATORY Opdivo Clears MHLW Panel for 3rd Line Use in Gastric Cancer, Keytruda to Lose Sakigake Status

September 8, 2017
BUSINESS Chugai to Expand Range of Drugs on Its Medication Optimization Support Application

September 8, 2017
ACADEMIA AMED Study Group to Investigate Drugs to Recommend in Elderly Depression Patients; Findings to Be Reflected in New Guidelines

September 7, 2017
BUSINESS Spera Pharma Begins Business Capitalizing on “Takeda’s” Track Record, Aims to Become Japan’s No. 1 CDMO

September 6, 2017
ORGANIZATION JMA’s Imamura Questions Distribution Coefficient in Cost Calculation Formula

September 5, 2017
BUSINESS Mitsubishi Tanabe to Beef Up Marketing System in Field of Autoimmune Diseases, Plans to Expand Expert Sales Force

September 5, 2017
REGULATORY Spinraza Add’l Indication Reported to MHLW Panel, Setting Stage for Its Use in All SMA Patients

September 4, 2017
REGULATORY Programs Funded by MA Holder or Its Subsidiaries Subject to Regulations under Clinical Research Law

September 1, 2017
BUSINESS Daiichi Sankyo Denies Report on AZ’s Acquisition Offer

September 1, 2017
BUSINESS Daiichi Sankyo Share Trade Halted after Report on AZ’s Acquisition Offer

August 31, 2017
BUSINESS Fujifilm Holdings Aims to Achieve 500 Billion Yen in Healthcare Sales in FY2019

August 31, 2017
ACADEMIA Over 150 Clinical Trials of Epigenetic Drugs, Some with Novel Mechanisms of Action, Underway Worldwide

August 31, 2017
REGULATORY MHLW to Form Study Group to Address Leftover Vial Drug Issue, Weighs Multi-Dose Vials

August 30, 2017
BUSINESS Mitsubishi Tanabe to Create New Business by Fusing LLPs with Digital Technologies

August 30, 2017

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COLUMN

AI: Your New HR BFF (Not Your Replacement!)

By Philip Carrigan

Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…

COMMENTARY

Radioligand Therapy Faces Capacity Bottleneck in Japan, System Build-Out Needed to Deliver on Promise

By Koji Shimomura

Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…